Researcher Verification

Vayron Labs sells research compounds exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

I am at least 21 years of age.
I confirm I am a qualified researcher purchasing for in vitro / laboratory research only — not for human or veterinary use.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Not a researcher? Exit

Vayron labs

Free U.S. Shipping On Orders Over $200
Third-Party Tested for Purity & Potency
Use Code VAYRON10 For 10% Off Your First Order
Sale!

DSIP

Original price was: $55.00.Current price is: $44.99.

All products sold by Vayron Labs are intended exclusively for laboratory research purposes. These products are not intended for human consumption, veterinary use, diagnosis, treatment, cure, or prevention of any disease

Availability: 3 in stock

Guaranteed Safe Checkout

DSIP, commonly known as Delta Sleep-Inducing Peptide and also referred to as emideltide, is a synthetic nonapeptide identified by the amino-acid sequence WAGGDASGE.

The compound is documented in chemical reference databases under CAS 62568-57-4 and is supplied here as a research material for qualified laboratory and scientific applications.

Product Classification

Primary Category: Research Peptides
Scientific Category: Synthetic Nonapeptide
Secondary Category: Peptide Research Compounds
Product Type: Research Peptide

Catalog Tags

DSIP · Emideltide · Delta Sleep-Inducing Peptide · Synthetic Nonapeptide · Research Peptide · Laboratory Research · Research Material

Chemical Information

Compound: DSIP
Preferred Substance Name: Emideltide
Common Name: Delta Sleep-Inducing Peptide
Peptide Sequence: WAGGDASGE
CAS Number: 62568-57-4
Molecular Formula: C₃₅H₄₈N₁₀O₁₅
Molecular Weight: Approximately 848.8 g/mol
PubChem CID: 68816

Research Information

DSIP/emideltide is a defined nine-amino-acid peptide that has been investigated in scientific research involving peptide biology and neurobiological systems.

The compound is represented in FDA’s Substance Registration System under the preferred substance name EMIDELTIDE, with DSIP and Delta Sleep-Inducing Peptide listed as synonyms. FDA’s registry also makes clear that a substance’s UNII listing does not mean that the substance has undergone FDA regulatory review or approval.

FDA’s 2026 Pharmacy Compounding Advisory Committee materials evaluated emideltide (free base) and emideltide acetate as separate bulk drug substances. FDA states that neither is a component of an FDA-approved drug.

FDA has also identified potential concerns for compounded products containing emideltide, including possible immunogenicity for certain routes of administration and complexities involving peptide-related impurities and API characterization.

Accordingly, this listing is intentionally limited to compound identity, chemical characteristics, and research classification. It does not represent DSIP as a sleep treatment, medication, or therapeutic product.

Research Applications

DSIP may be examined as a research material in controlled laboratory environments for purposes such as:

Peptide characterization
Analytical testing
Structural investigation
Molecular research
Comparative peptide studies
Laboratory assay development
Neurobiological research
Peptide-related experimental research

These statements describe potential research contexts only and do not constitute recommendations for administration to humans or animals.

Product Specifications

Product Name: DSIP
Preferred Substance Name: Emideltide
Alternative Name: Delta Sleep-Inducing Peptide
Product Type: Synthetic research peptide
Primary Category: Research Peptides
Scientific Classification: Synthetic Nonapeptide
Sequence: WAGGDASGE
CAS: 62568-57-4
Molecular Formula: C₃₅H₄₈N₁₀O₁₅
Molecular Weight: ~848.8 g/mol
Intended Application: Laboratory and scientific research

Important Product Information

Chemical form must be verified before publishing the product specifications.

FDA distinguishes emideltide free base from emideltide acetate as separate bulk drug substances. PubChem likewise identifies DSIP acetate separately, with a molecular weight of approximately 908.9 g/mol.

Therefore, the specifications above should only be used when your actual material corresponds to DSIP/emideltide free base. If your supplier’s COA identifies the product as DSIP acetate, the product page should use the acetate-specific chemical information instead.

Product identity, peptide sequence, purity, salt form, analytical results, and other batch-specific specifications should be verified against the applicable Certificate of Analysis (COA).

Research Use Notice

This product is supplied solely as a research material for qualified laboratory and scientific use.

It is not intended for human consumption, human therapeutic use, veterinary use, diagnosis, treatment, mitigation, or prevention of disease.

Nothing on this product page should be interpreted as a recommendation or representation that DSIP/emideltide is intended to affect the structure or function of the human body.

Not for use as a drug, dietary supplement, food, cosmetic, or medical treatment.

For laboratory research purposes only.

Scroll to Top